Molina Healthcare (NYSE: MOH) reported Q3 EPS of $2.97, versus $1.64 reported last year. Revenue for the quarter came in at $4.7 billion versus the consensus estimate of $4.7 billion.

• Net income of $2.90 per diluted share on a GAAP basis for the third quarter of 2018, and $7.60 for the nine months ended September 30, 2018
• Third quarter 2018 results include a net charge of $0.35 per diluted share, and year-to-date results include a net benefit of $0.59 per diluted share, for non-run rate items
• The overall medical care ratio improved to 86.4% from 87.0%, sequentially, when excluding non-run rate items
• Net profit margin of 4.2% in the quarter, and 3.6% year to date
• 2018 guidance increases by $1.65 per diluted share at the midpoint, to a range of $8.80 - $9.00 net income per diluted share on a GAAP basis

“We are very pleased with the continued improvement in the performance of our business,” said Joe Zubretsky, President and Chief Executive Officer. “Our financial results reflect the significant progress we are making in executing our margin recovery and sustainability plan.”

GUIDANCE:

Molina Healthcare sees FY2018 EPS of $8.80-$9.00, versus the consensus of $7.52. Molina Healthcare sees FY2018 revenue of $18.8 billion, versus the consensus of $18.85 billion.

For earnings history and earnings-related data on Molina Healthcare (MOH) click here.